May 4, 2010 — Lamotrigine is the most effective antiepileptic drug (AED) in older adults with epilepsy, with levetiracetam a close second, according to the results of a retrospective review of 10 AEDs ...

The multicenter retrospective study included 543 mostly White women of childbearing age with IGE according to International League Against Epilepsy (ILAE) diagnostic criteria — a population facing ...

Medically reviewed by Mary Choy, PharmD Key Takeaways Tegretol and Lamictal are prescription medications used to help control seizures in people with epilepsy.Lamictal is used to treat both seizures ...

Please provide your email address to receive an email when new articles are posted on . Researchers observed differences in survival between antiseizure medications in post-stroke epilepsy, with ...

The FDA on Wednesday updated its warning about potential increased arrhythmia risk in people with cardiac disease who are taking the seizure and mental health drug lamotrigine (Lamictal) with new data ...

LOS ANGELES -- The FDA's warning about arrhythmia risk with lamotrigine (Lamictal) based on in vitro data wasn't borne out in observational cohorts of people with epilepsy, although the risk did ...

GlaxoSmithKline announced that the FDA has approved Lamictal XR (lamotrigine extended-release tablets) as a once-a-day add-on therapy for epilepsy patients ≥13 years of age with partial onset seizures ...

Boston, MA, May 1, 2007 -- Data from two clinical trials presented today at the American Academy of Neurology (AAN) meeting suggest that an investigational once daily extended release formulation of ...

LISLE, IL, UNITED STATES, January 12, 2026 /EINPresswire.com/ -- OWP Pharmaceuticals today announced commercial product ...

Common side effects include sleepiness, headache, vomiting, trouble with coordination, and rash. Lamotrigine was first marketed in the United Kingdom in, and approved for use in the United States in ...

Lamictal epilepsy drug during the first three months of pregnancy may increase the chances of having a baby with a cleft lip or palate, U.S. regulators warned on Friday. “More research is needed to be ...